73 related articles for article (PubMed ID: 1575885)
1. The uptake kinetics of chimeric oligodeoxynucleotide analogues in human leukaemia MOLT-4 cells.
Spiller DG; Tidd DM
Anticancer Drug Des; 1992 Apr; 7(2):115-29. PubMed ID: 1575885
[TBL] [Abstract][Full Text] [Related]
2. Chimeric oligodeoxynucleotide analogues: enhanced cell uptake of structures which direct ribonuclease H with high specificity.
Giles RV; Spiller DG; Tidd DM
Anticancer Drug Des; 1993 Feb; 8(1):33-51. PubMed ID: 8386514
[TBL] [Abstract][Full Text] [Related]
3. Enhanced RNase H activity with methylphosphonodiester/phosphodiester chimeric antisense oligodeoxynucleotides.
Giles RV; Tidd DM
Anticancer Drug Des; 1992 Feb; 7(1):37-48. PubMed ID: 1311929
[TBL] [Abstract][Full Text] [Related]
4. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.
Nakai D; Seita T; Terasaki T; Iwasa S; Shoji Y; Mizushima Y; Sugiyama Y
J Pharmacol Exp Ther; 1996 Sep; 278(3):1362-72. PubMed ID: 8819524
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages.
Shoji Y; Akhtar S; Periasamy A; Herman B; Juliano RL
Nucleic Acids Res; 1991 Oct; 19(20):5543-50. PubMed ID: 1658734
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of N-ras oncogene anti-sense, sense and nonsense sequence methylphosphonate oligonucleotide analogues.
Tidd DM; Hawley P; Warenius HM; Gibson I
Anticancer Drug Des; 1988 Aug; 3(2):117-27. PubMed ID: 2457379
[TBL] [Abstract][Full Text] [Related]
8. c-Met antisense oligodeoxynucleotides as a novel therapeutic agent for glioma: in vitro and in vivo studies of uptake, effects, and toxicity.
Chu SH; Zhang H; Ma YB; Feng DF; Zhu ZA; Yuan XH; Li ZQ
J Surg Res; 2007 Aug; 141(2):284-8. PubMed ID: 17561117
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake of phosphorothioate oligodeoxynucleotides is negatively affected by cell density in a transformed rat tracheal epithelial cell line: implication for antisense approaches.
Iwanaga T; Ferriola PC
Biochem Biophys Res Commun; 1993 Mar; 191(3):1152-7. PubMed ID: 8466492
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake and localization of liposomal-methylphosphonate oligodeoxynucleotides.
Tari AM; Andreeff M; Kleine HD; Lopez-Berestein G
J Mol Med (Berl); 1996 Oct; 74(10):623-8. PubMed ID: 8912183
[TBL] [Abstract][Full Text] [Related]
11. Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.
Giles RV; Tidd DM
Nucleic Acids Res; 1992 Feb; 20(4):763-70. PubMed ID: 1371864
[TBL] [Abstract][Full Text] [Related]
12. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
Ginobbi P; Geiser TA; Ombres D; Citro G
Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
[TBL] [Abstract][Full Text] [Related]
13. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
Reed JC; Stein C; Subasinghe C; Haldar S; Croce CM; Yum S; Cohen J
Cancer Res; 1990 Oct; 50(20):6565-70. PubMed ID: 2208117
[TBL] [Abstract][Full Text] [Related]
14. Calcium dependent cellular uptake of a c-myc antisense oligonucleotide.
Wu-Pong S; Weiss TL; Hunt CA
Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):843-50. PubMed ID: 7812192
[TBL] [Abstract][Full Text] [Related]
15. Sequence-specific inhibition of gene expression in intact human skin by epicutaneous application of chimeric antisense oligodeoxynucleotides.
Wingens M; Pfundt R; van Vlijmen-Willems IM; van Hooijdonk CA; van Erp PE; Schalkwijk J
Lab Invest; 1999 Nov; 79(11):1415-24. PubMed ID: 10576212
[TBL] [Abstract][Full Text] [Related]
16. Multigene targeting with antisense oligodeoxynucleotides: an exploratory study using primary human leukemia cells.
Opalinska JB; Machalinski B; Ratajczak J; Ratajczak MZ; Gewirtz AM
Clin Cancer Res; 2005 Jul; 11(13):4948-54. PubMed ID: 16000594
[TBL] [Abstract][Full Text] [Related]
17. Mode of uptake of 5'-cholesteryl-linked phosphodiester oligodeoxynucleotides in HL60 cells.
Stein CA; Yakubov L; Zhang LM; Tonkinson J
Nucleic Acids Symp Ser; 1991; (24):155-6. PubMed ID: 1841271
[No Abstract] [Full Text] [Related]
18. Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20.
Liao Y; Tang ZY; Ye SL; Liu KD; Sun FX; Huang Z
Hepatogastroenterology; 2000; 47(32):365-70. PubMed ID: 10791191
[TBL] [Abstract][Full Text] [Related]
19. Number and distribution of methylphosphonate linkages in oligodeoxynucleotides affect exo- and endonuclease sensitivity and ability to form RNase H substrates.
Quartin RS; Brakel CL; Wetmur JG
Nucleic Acids Res; 1989 Sep; 17(18):7253-62. PubMed ID: 2477796
[TBL] [Abstract][Full Text] [Related]
20. Non-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells.
de Semir D; Petriz J; Avinyó A; Larriba S; Nunes V; Casals T; Estivill X; Aran JM
J Gene Med; 2002; 4(3):308-22. PubMed ID: 12112648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
